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ABSTRACT 20 
Despite the growing quantity of literature exploring the effect of caffeine on muscular 21 
strength, there is a dearth of data that directly explores differences in erogenicity 22 
between upper and lower body musculature and the dose response effect. The 23 
present study sought to investigate the effects of low and moderate dose caffeine on 24 
the maximal voluntary strength of the elbow flexors and knee extensors. Ten non-25 
specifically strength trained, recreationally active participants (21 ± 0.3 yrs) completed 26 
the study. Using a randomised, counterbalanced and double blind approach, isokinetic 27 
concentric and eccentric strength was measured at 60 and 180 deg/s following 28 
administration of a placebo, 3 mg・kg−1 body mass caffeine and 6 mg・kg−1 body 29 
mass caffeine. There was no effect of caffeine on the maximal voluntary concentric 30 
and eccentric strength of the elbow flexors, or the eccentric strength of the knee 31 
extensors. Both 3 and 6 mg・kg−1 body mass caffeine caused a significant increase 32 
in peak concentric force of the knee extensors at 180 deg/s. No difference was 33 
apparent between the two concentrations. Only 6 mg・kg−1 body mass caused an 34 
increase in peak concentric force during repeated contractions. The results infer that 35 
the effective caffeine concentration to evoke improved muscle performance may be 36 
related to muscle mass and contraction type. The present work indicates that relatively 37 
low dose caffeine treatment may be effective for improving lower body muscular 38 
strength, but may have little benefit for the strength of major muscular groups of the 39 
upper body. 40 
 41 
Key Words: Ergogenic Aids, Isokinetic Dynamometry, Skeletal Muscle, Strength, 42 
Maximal Voluntary Contraction, Repeated Contractions  43 
3 
 
INTRODUCTION 44 
Caffeine (common name for 1,3,7-trimethlyxanthine) is one of the most commonly 45 
consumed drugs in the world (Nawrot et al. 2003), and the vast quantity of scientific 46 
literature documenting its ability to elicit improvements in both cognition (Nehlig 2010) 47 
and exercise performance (Graham 2001; Davis et al. 2009) have made it a popular 48 
nutritional supplement consumed by recreational and elite athletes as a method to 49 
evoke a legal, and sometimes substantial, improvement in performance. Generally, it 50 
is considered that caffeine has the potential to improve performance in endurance, 51 
power and strength based activities (Graham 2001), and there are a number of 52 
published literature reviews and meta-analyses (Graham 2001; Magkos et al. 2005; 53 
Burke 2008; Davis and Green 2009; Astorino et al. 2010a; Warren et al. 2010) that 54 
substantiate this.  55 
Although generally there seems to be support for a caffeine induced improvement in 56 
strength performance (Astorino and Roberson 2010a; Warren, Park et al. 2010), 57 
findings from research exploring the caffeine effect using such exercise modalities 58 
appear to be more equivocal than studies examining the ergogenic properties of 59 
caffeine using endurance based exercise protocols. Despite the likely publication bias 60 
that exist within this field, where research studies showing effects are favoured, there 61 
are still many studies that fail to demonstrate an effect of caffeine on muscular strength 62 
(Bond et al. 1986; Jacobson et al. 1991; Jacobs et al. 2003; Astorino et al. 2008; 63 
Williams et al. 2008; Tallis et al. 2013). The degree of ambiguity can largely be 64 
attributed to differences in the caffeine dose and method of administration, the 65 
exercise protocol (i.e. 1 repetition maximum, repetitions until failure, maximal voluntary 66 
contractions), the muscle group tested, the possibility of habituation in high caffeine 67 
users, and differences that may be apparent between specifically trained and novice 68 
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participants. Despite this, caffeine use amongst strength and power athletes is rife 69 
(Van Thuyne et al. 2005; Del Coso et al. 2011), and as such, further research is 70 
needed to more accurately quantify the caffeine effect. 71 
A meta-analysis by Warren, Park et al. (2010), demonstrated that caffeine elicited a 72 
small ergogenic effect on measures of maximal voluntary force, with lower body or 73 
larger muscle groups demonstrating a greater benefit compared to upper body or small 74 
muscle groups. This phenomenon was attributed to a lower neural activation of larger 75 
muscle groups and the mechanistic action of caffeine to act via the central nervous 76 
system (CNS) to promote greater muscular recruitment. As such, these findings further 77 
rationalise the equivocal results demonstrated in studies evaluating the effect of 78 
caffeine on muscular strength. Interestingly, conclusions by Warren, Park et al. (2010) 79 
are based largely on indirect comparisons of studies that have assessed the effect of 80 
caffeine on one of either upper body or lower body strength. Black et al. (2015) 81 
demonstrated that a 5 mg・kg−1 caffeine treatment resulted in an increased maximal 82 
voluntary isometric force and motor unit activation of the knee extensors. However, 83 
this dose failed to elicit any effect on the muscular strength of the elbow flexors in the 84 
same set of participants. Beyond this work there is a distinct lack of research data that 85 
examines the effect of caffeine on maximal voluntary force using different muscle 86 
groups in the same participant. The present study builds on work by Black, Waddell et 87 
al. (2015) by examining the effect of caffeine dose on upper body and lower body 88 
maximal voluntary force during concentric and eccentric muscle activity. 89 
Typically, researchers’ examining the ergogenic effect of caffeine on exercise 90 
performance have done so using moderate doses (5-6 mg・kg−1 body mass) that are 91 
dissolved in fluid and consumed orally (Plaskett et al. 2001; Green et al. 2007; Astorino 92 
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et al. 2010b; Timmins et al. 2014; Tallis et al. 2016). Doses between 2.5 to 7 mg・93 
kg−1 body mass has been reported to improve high intensity exercise performance 94 
(Astorino and Roberson 2010a), however it is widely accepted that within and above 95 
this concentration range, caffeine fails to elicit a dose dependant effect irrespective of 96 
exercise modality. It is surprising however that based on an evaluation of the available 97 
literature, this conclusion has been derived from a relatively small number of studies, 98 
with a fewer number directly assessing dose response effects in measurements of 99 
muscular strength (Jacobson and Edwards 1991; Astorino, Terzi et al. 2010b; Del 100 
Coso et al. 2012). Of these studies, Jacobson and Edwards (1991) failed to 101 
demonstrate any performance enhancing benefit irrespective of treatment dose, while 102 
Del Coso, Salinero et al. (2012) demonstrated that 3 mg・kg−1 body mass elicited an 103 
improvement in half-squat and bench-press performance that was not seen using a 1 104 
mg・kg−1 body mass treatment. Similarly, Astorino, Terzi et al. (2010b) demonstrated 105 
a positive effect of 5 mg・kg−1 body mass caffeine on peak knee flexion torque, knee 106 
extension/flexion total work, and knee extension/flexion power, but no effect on the 107 
same measures when using a 2 mg・kg−1 body mass concentration. 108 
Given the ambiguity in research examining the effect of caffeine on muscle strength 109 
and the distinct lack of studies examining the dose response relationship, further 110 
research is warranted to evaluate the dose dependant effects of caffeine on maximal 111 
voluntary muscle force in both the upper and lower body using concentrations between 112 
2.5 and 7 mg・kg−1 body mass, which has previously been outlined as the dose 113 
needed to elicit a positive response (Astorino and Roberson 2010a). In addition, there 114 
needs to be further focus of the dose response effect of caffeine treatment on eccentric 115 
measures of muscle contractility, given the importance of this type of muscle activity 116 
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for sports performance (i.e. change of direction, declaration, movement control). 117 
Considering this, the present study aimed to assess the effects of low and moderate 118 
dose caffeine supplementation on the maximal voluntary concentric and eccentric 119 
force of the elbow flexors and knee extensors in the same participant. As such, the 120 
study provides important insight as to whether caffeine elicits a dose response effect 121 
on both concentric and eccentric measurements of muscle strength, and further 122 
considers whether caffeine supplementation has a greater performance enhancing 123 
benefit in upper or lower body regions. It is hypothesised that only the moderate 5 mg124 
・kg−1 body mass caffeine treatment will elicit improved muscular strength of the 125 
elbow flexors. However, the low 3 mg・kg−1 body mass dose will induce improved 126 
performance of the knee extensor musculature, with a trend for a greater ergogenic 127 
benefit with the moderate dose.  128 
 129 
 130 
 131 
 132 
 133 
 134 
 135 
 136 
 137 
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MATERIALS & METHOD 138 
Following ethical approval from the host institute and completion of informed consent, 139 
ten apparently healthy, recreationally active (participating in physical activity 2-3 times 140 
per week for longer than 6 months), but non-specifically strength trained males (Mean 141 
± SE: Age: 21 ± 0.3 yrs; height: 176 ± 2.1; body mass: 73.9 ± 3.4) agreed to participate 142 
in the study. Participants were low  habitual caffeine users (Mean ± SE; 122 ± 40.9 143 
mg/day) as identified by the completion of a caffeine consumption questionnaire 144 
(Maughan 1999). 145 
Participants were asked to attend the human performance laboratory at Coventry 146 
University on four occasions. As per the procedures of previous research investigating 147 
the performance enhancing effect of caffeine, participants were asked to abstain from 148 
caffeine consumption and physical activity 48 hours prior to each session (Astorino, 149 
Rohmann et al. 2008; Tallis, Muhammad et al. 2016). Each visit to the laboratory was 150 
separated by at least 48 hours, and participants were asked to attend at the same time 151 
of day to avoid circadian variation.  152 
Familiarisation 153 
The intention of the first visit was to familiarise participants to the experimental 154 
procedures to be used in the study. Initially, shoes and heavy clothing were removed 155 
and measures of height (cm) and body mass (kg) were taken using a stadiometer 156 
(SECA Instruments Ltd., Germany) and electronic weighing scales (SECA Instruments 157 
Ltd., Germany).  Participants then completed a standardised upper body warm-up 158 
consisting of 5 minutes of arm crank ergometry (Monark 857E Ergomedic, Monark, 159 
Varberg, Sweden) using an unloaded cradle and a fixed cadence of 70rpm, 160 
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immediately followed by 5 minutes of static and dynamic stretches, focusing on the 161 
elbow flexors (biceps brachii and brachialis). 162 
Average and maximal voluntary isokinetic force (N) of the elbow flexors for the 163 
dominant side was then measured using an isokinetic dynamometer (Kin-Com 125 164 
AP, Chattanooga Tennessee USA), which was set up in accordance with the 165 
manufacturer’s instructions. Each participant was strapped to the dynamometer chair 166 
in a seated position with the ipsilateral leg anchored behind the shin attachment. The 167 
rotational axis of the dynamometer head was aligned with the lateral epicondyle of the 168 
humorous on the dominant side, with an elbow rest positioned relative to this. A hand 169 
grip bar at the opposing end of the leaver arm was adjusted relative to the length of 170 
the hand and forearm to allow the participant a comfortable grip. During concentric 171 
measures, participants were instructed to pull upwards on the bar as hard a possible 172 
through a fixed range of 80° - 120° (relative to anatomical zero for the elbow). During 173 
eccentric measures, participants were asked to resist the movement of the leaver arm 174 
moving from 120° - 80°. Measures of average and maximal concentric and eccentric 175 
force were measured at fixed speeds of 60 deg/s and 180 deg/s. Participants used the 176 
inbuilt warm-up feature of the dynamometer to become familiarised with the 177 
movements and test speeds. During the assessment of maximal voluntary force, 178 
participants performed a series of tests at each speed until maximal force was 179 
determined (usually within 3 attempts). Attempts were separated by a 60 second rest 180 
period. On completion, participants performed 30 consecutive repetitions at 180 deg/s, 181 
and maximal concentric and eccentric force was recorded for each repetition. All force 182 
values collected were corrected for gravity effects by estimation of limb weight (elbow 183 
fixed at 90°) prior to the assessment of maximal voluntary force. 184 
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Participants then completed a standardised warm up of the lower body, consisting of 185 
5 minutes of cycling (Monark 824E Ergomedic, Monark, Varberg, Sweden) using an 186 
unloaded cradle and a fixed cadence of 70rpm, immediately followed by 5 minutes of 187 
static and dynamic stretches, focusing on the knee extensors (vastus intermedius, 188 
vastus medialis, vastus lateralis and rectus remoris). 189 
The isokinetic dynamometer was then set up for the assessment of the average and 190 
maximal voluntary isokinetic force (N) of knee extensors in accordance with published 191 
protocols (Tallis, Duncan et al. 2013; Tallis, Muhammad et al. 2016). Each participant 192 
was strapped to the dynamometer chair in a seated position, and the leaver arm axis 193 
of rotation was aligned with the lateral femoral epicondyle of the dominant limb. The 194 
distal end of the leaver arm was fitted with a shin pad which was aligned with the lateral 195 
malleolus. A strap was placed across the midpoint of the upper limb of the test leg. 196 
Throughout the duration of the test participants were instructed to keep their arms 197 
fixed across the chest. The range of motion was fixed 10°-80° (relative to anatomical 198 
zero for the knee). The testing protocol was then carried out in the way as that 199 
described for the assessment of maximal voluntary force of the elbow flexors. All force 200 
values collected were corrected for gravity effects by estimation of limb weight carried 201 
out according to the manufacturer’s instructions (knee fixed at anatomical zero). This 202 
was measured prior to the assessment of maximal voluntary force. 203 
The dynamometer positions for upper and lower body assessments were stored and 204 
recalled during subsequent visits. 205 
Experimental Procedures 206 
Participants were asked to consume a similar diet for the 24h prior to each 207 
experimental trial. Compliance was verbally acknowledged on arrival to the laboratory 208 
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at each visit. Upon arrival to the laboratory, participants were fitted with telemetric HR 209 
monitor (Polar FS1, Kempele, Finland), and then began 5 minutes of seated rest. Upon 210 
completion HR was measured. Participants then consumed one of the three 211 
experimental solutions; placebo, 3 mg・kg−1 body mass caffeine, 6 mg・kg−1 body 212 
mass caffeine.  213 
Experimental solutions were administered in a double-blinded, counterbalanced and 214 
randomised fashion. Caffeine drinks contained either 3 or 6 mg・kg−1 body mass of 215 
caffeine (Myprotein, UK) diluted in 4 ml・kg−1 body mass water and 1 ml・kg−1 body 216 
mass double concentrate sugar free orange cordial (Sainsbury’s, UK), and were 217 
artificially sweetened with 3 mg・kg−1 body mass sucralose (Myprotein, UK). Placebo 218 
solutions were prepared in the same way with the absence of caffeine. 3 mg・kg−1 219 
body mass caffeine has commonly been cited as the lowest concentration needed to 220 
elicit a performance enhancing effect (Graham 2001; Astorino and Roberson 2010a), 221 
whilst 6 mg・kg−1 body mass is used regularly to represent a moderate caffeine dose 222 
(Plaskett and Cafarelli 2001; Green, Wickwire et al. 2007; Astorino, Terzi et al. 2010b; 223 
Timmins and Saunders 2014; Tallis, Muhammad et al. 2016). Each solution was 224 
served in an identical opaque sports bottle and on no occasion did participants 225 
disclose to the research team they knew the content of the solution. Participants were 226 
asked to fully consume the contents within 5 minutes and then rested for 45 minutes, 227 
which was immediately followed by a measure of resting HR. Participants then 228 
completed the warm up procedure as previously described. The strength assessments 229 
began 60 minutes post-ingestion in line with previous evidence that demonstrates 230 
maximal blood plasma concentration of caffeine occurs one hour post-consumption 231 
(Graham 2001). The strength assessments were carried out using the isokinetic 232 
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dynamometer in the same manner as previously described. Prior to and immediately 233 
following the 30 repeated contractions, HR and Perception of pain using Cook’s Pain 234 
scale (Cook et al. 1998) were measured.   235 
Statistical Method 236 
Normality and homogeneity of variance were tested using Shapiro–Wilk and Mauchly 237 
tests respectively. Where data was non-normally distributed, log10 transformation was 238 
performed and normality re-assessed. Eight 3 (treatment) x 2 (speed) factor repeated 239 
measures ANOVA’s were performed on both biceps and quadriceps maximal and 240 
average eccentric and concentric force data. This was repeated in order to assess a 241 
potential order effect of treatment administration. In order to determine the effect of 242 
caffeine treatment on muscle performance during the repeated contractions protocol, 243 
four 3 (treatment) x 30 (rep) factor repeated measures ANOVA’s were performed for 244 
both the biceps and quadriceps concentric and eccentric data. Violations of sphericity 245 
were corrected using Greenhouse–Geisser where applicable.  246 
HR was analysed using a 3 (treatment) x 6 (time) repeated measures ANOVA. 247 
Similarly, perception of pain was analysed using a 3 (treatment) x 2 (time) repeated 248 
measure ANOVA, using non-normally distributed data in order to avoid type one error 249 
when performing multiple non-parametric tests. 250 
Where appropriate, pairwise comparisons with LSD corrections were performed to 251 
identify differences between each treatment. Partial eta squared (η2) was used as a 252 
measure of effect size and was reported for significant ANOVA main effects. Partial η2 253 
is commonly used in analysis of variance and provides a measure of the variance in 254 
the dependant variable attributable to the factor in question (Tabachnick et al. 2006). 255 
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In other instances, effect size (d) was calculated using the differences in means 256 
divided by the pooled SD of the compared trials (Nakagawa et al. 2007) 257 
Data are presented as mean ± SE. Statistical analysis was performed using SPSS 258 
22.0 (Chicago, IL, USA). Statistical significance was set at a level of P<0.05. 259 
  260 
 261 
 262 
 263 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
 272 
 273 
 274 
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RESULTS 275 
The statistical results indicate that there was no order effect of treatment 276 
administration (F(2, 18)<2.79; P>0.07). This therefore dictates that any treatment effect 277 
on the measured variables herein were due to an effect of caffeine. 278 
Upper Body 279 
Maximal concentric and eccentric force of the elbow flexors was not significantly 280 
affected by treatment (Fig 1A & B. F(2, 18)=<0.53; P>0.72). The maximal concentric 281 
force of the elbow flexors was significantly reduced at 180 deg/s compared to 60 deg/s 282 
(Fig 1A. F(1, 9)=9.63; P=0.013; Pη2=0.52), however the maximal eccentric force was 283 
unaffected by speed (Fig 1B F(1, 9)=0.14; P=0.72). There was no significant 284 
treatment*speed interaction in each case (Fig 1A & B. F(2, 18)=0.759 & F(1, 11)=0.607 285 
receptively; P>0.48). Similarly, the average concentric and eccentric work of the elbow 286 
flexors was unaffected by treatment (Fig 1C & D. F(2, 18)<0.25; P>0.77). The average 287 
concentric and eccentric force of the elbow flexors was significantly lower at the 288 
greater angular velocity (Fig 1C & D. F(1, 9)>6.39; P<0.04; Pη2>0.41). There was no 289 
significant treatment*speed interaction in each case (Fig 1C & D. F(2, 18)< 1.9; P>0.17).   290 
Lower Body  291 
Two factor repeated measures ANOVA revealed a significant treatment*speed 292 
interaction for maximal concentric force of the knee extensors (F(2, 18)=4.64; P=0.024), 293 
and subsequently the effect of treatment was analysed independently at each speed 294 
using single factor ANOVA. There was no effect of caffeine treatment on maximal 295 
concentric force tested at 60 deg/s (Fig 2A. F(2, 18)=0.334; P=0.721). The main effect 296 
for treatment was significant for tests at 180 deg/s (Fig 2A. F(2, 18)=4.16; P=0.033; 297 
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Pη2=0.316). LSD Pairwise comparisons demonstrated that force was significantly 298 
greater following consumption of the moderate dose caffeine (P=0.033; d=0.68) and 299 
had a statistical tendency to be greater following consumption of the low dose of 300 
caffeine (P=0.083; d=0.83), when compared to the placebo control. There was 301 
however no difference in response between the low and moderate caffeine dose 302 
(P=0.643). 303 
Average concentric and maximal and average eccentric force of the knee extensors 304 
was not affected by treatment (Fig 2B, C & D. F(2, 18)<2.60; P>0.104). Average 305 
concentric and eccentric force was significantly lower at the higher test speeds (Fig 306 
2C & D. F(1, 9)>26.04; P<0.001; Pη2>0.74), but maximal eccentric force was unaffected 307 
by speed (Fig 2B. F(1, 9)=0.595; P=0.460). No significant treatment*speed interactions 308 
were found for these variables (F(2, 18)<2.31; P>0.128 in each case). 309 
Maximal Repeated Contractions 310 
The main effect for treatment was approaching significance for the maximal concentric 311 
force of the knee extensors during the repeated contractions protocol (Fig 3C. F F(2, 312 
18)=3.04; P=0.073; Pη2=0.253), with pairwise comparisons demonstrating that this 313 
difference was apparent in the moderate caffeine dose (P=0.059; d=0.47), but not the 314 
low caffeine dose (P=0.241) when compared to the placebo trial.  315 
The repeated maximal performance of the knee extensors activated eccentrically and 316 
the elbow flexors activated both concentrically and eccentrically were not significantly 317 
different between the treatments (Fig 3A, B & D. F(2, 18)<2.46; P>0.123). For all four of 318 
the dependant variables, force over the time course of the test was significantly 319 
affected by time (Fig 3. F(29, 261)>1.9; P<0.005; Pη2>0.17), and there was no significant 320 
treatment*rep interaction (Fig 3.F(58, 522)<1.296; P>0.081). 321 
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HR & Perception of Pain 322 
Perception of pain for the arms and the legs was not significantly affected by treatment 323 
(Fig 4A. F(2, 18)<1.00 P>0.386), although in both cases the perception of pain was 324 
significantly higher immediately following completion of the respective repeated 325 
contractions protocol (Fig 4A. F(1, 9)>11.00; P<0.01 Pη2>0.54). There was no significant 326 
treatment*time interaction (Fig 4A. F(2, 18)<0.195; P>0.825).  327 
HR was not significantly affected by treatment (Fig 4B. ANOVA F(2, 18)=0.39; P=0.704), 328 
but was significantly affected by time (Fig 4B. F(3, 22)=82.70; P<0.001; Pη2=902). There 329 
was no significant treatment*time interaction (Fig 4B. F(12, 108)=0.97; P=0.480). 330 
 331 
 332 
 333 
 334 
 335 
 336 
 337 
 338 
 339 
 340 
 341 
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DISCUSSION 342 
Results from the present study indicate that caffeine may be an effective nutritional 343 
supplement to induce some improvements in the maximal voluntary strength of non-344 
specifically trained individuals. It appears however that these benefits may be limited 345 
to the concentric activity of lower limb muscle working at a higher contraction velocity, 346 
as there were no measured effects of caffeine (irrespective of concentration) on the 347 
contractile measures of the elbow flexors or eccentric measures of the knee extensors. 348 
Although some aspects of contractility appeared to be improved using the low 3 mg・349 
kg−1 body mass caffeine dose, the 6 mg・kg−1 body mass caffeine treatment 350 
appeared to be more effective in eliciting a performance enhancing response. Despite 351 
this, the results fail to demonstrate a clear dose response relationship, rather the 352 
effective caffeine concentration to evoke improved muscle performance may be 353 
related to muscle mass and contraction type. 354 
The demonstrated increase in peak concentric strength of the knee extensors and 355 
performance during the repeated repetitions protocol, adds further weight to the 356 
growing body of evidence that demonstrates that caffeine may be effective in 357 
improving strength performance (Jacobson et al. 1992; Hoffman et al. 2008; Woolf et 358 
al. 2008; Astorino, Terzi et al. 2010b; Del Coso, Salinero et al. 2012; Tallis, 359 
Muhammad et al. 2016). The lack of response in all other measures however help to 360 
further rationalise the equivalent evidence in this area of research (Bond, Gresham et 361 
al. 1986; Jacobson and Edwards 1991; Jacobs, Pasternak et al. 2003; Astorino, 362 
Rohmann et al. 2008; Williams, Cribb et al. 2008; Tallis, Duncan et al. 2013). The 363 
present findings infer that the caffeine response may be effected by treatment 364 
concentration, muscle group tested, and elicit diverse effects during different 365 
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contractile activity within the same individual. As such these findings demonstrate a 366 
further complexity with respect to identifying the optimum conditions for a caffeine 367 
induced increase in muscle strength. 368 
Upper Body vs. Lower Body 369 
This data fills a gap in the literature whereby there is a distinct lack of studies that 370 
directly examine the effect of caffeine on upper body and lower body maximal 371 
voluntary force. Timmins and Saunders (2014) demonstrated that a 6 mg・kg−1 body 372 
mass was effective at increasing the peak concentric torque of the knee, elbow and 373 
wrist flexors, and the ankle plantar flexors in resistance trained participants. However, 374 
the performance enhancing benefit was greatest in the knee extensors, and was 375 
reduced in the smaller elbow and wrist flexor muscle groups. The lack of response 376 
seen in the elbow flexors of the present study is in agreement with work conducted by 377 
Black, Waddell et al. (2015) and would appear to contradict this previous work. This 378 
may therefore indicate that the performance enhancing benefit of caffeine is not 379 
concurrent across all muscles. This discrepancy is likely to relate to differences 380 
between the trained and the untrained participants used in the present study compared 381 
to previous work. It is considered that the ergogenic benefit is greater in specifically 382 
trained participants, rationalised by a greater motivation to repeatedly produce 383 
maximal efforts (Astorino and Roberson 2010a). This could further relate to the ability 384 
of caffeine to act directly at the muscle (Tallis et al. 2015) via increased Ca2+ release 385 
from the sarcoplasmic reticulum, the efficiency of which is likely to be improved in 386 
trained individuals (Munkvik et al. 2010). 387 
In general, the current findings further support the conclusion of Warren, Park et al. 388 
(2010), who demonstrated using indirect comparisons, that caffeine would elicit a 389 
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greater improvement in muscular strength of lower body or larger muscle groups 390 
compared to upper body or small muscle groups. The present findings also further 391 
previous work examining the effect of caffeine on upper and lower body maximal 392 
voluntary force (Timmins and Saunders 2014), by uniquely demonstrating that the 393 
discrepancies between the improvement in maximal force of lower body musculature 394 
and the lack of response seen in upper body musculature is concurrent across acute, 395 
one-off maximal contractile function and a protocol of sustained contractions. 396 
Dose Response Effect 397 
Given the ambiguity and the distinct lack of evidence, the present study sought to 398 
further examine the dose response effect of caffeine on muscular strength. The data 399 
indicates that where caffeine acted to elicit a performance enhancing response, there 400 
was no clear dose response effect. The lower dose of caffeine (3 mg・kg−1 body 401 
mass) elected an increase in the peak concentric force of the knee extensors at 180 402 
deg/s that was approaching significance and equal in magnitude to the increase seen 403 
using the moderate caffeine dose (6 mg・kg−1 body mass), which did reach statistical 404 
significance when compared to the placebo condition. Given that there was no 405 
significant difference in the response between the low and moderate caffeine doses, 406 
these results indicate that lower doses of caffeine, which are closer in concentration 407 
to that of commercially available products, may be effective in increasing some 408 
aspects of muscular strength in an equal proportion to that achieved using a much 409 
higher concentration. The present results infer that greater doses fail to elicit a superior 410 
response, rather there is a threshold concentration whereby caffeine either elicits a 411 
positive outcome, or fails to have an effect. A similar conclusion has been 412 
demonstrated in a study examining the dose response effect of physiological 413 
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concentrations of caffeine on mammalian isolated skeletal muscle contractility (Tallis 414 
et al. 2012).  415 
Astorino, Terzi et al. (2010b) demonstrated a positive effect of 5 mg・kg−1 body mass 416 
caffeine on peak knee flexion torque, knee extension/flexion total work, and knee 417 
extension/flexion power, but no effect of the same measures when using a 2 mg・418 
kg−1 body mass concentration. Our results in part support these findings 419 
demonstrating that the higher 6 mg・kg−1 body mass dose was effective in inducing 420 
improvements in peak concentric force of the knee extensors at 180 deg/s and 421 
sustained performance during repeated contractions. However, unlike the 2 mg・kg−1 422 
body mass concentration used by Astorino, Terzi et al. (2010b), 3 mg・kg−1 body 423 
mass caffeine treatment in the present study was effective at eliciting an improvement 424 
in peak muscular strength. This difference may be apparent as lower dose of caffeine 425 
used in the current study falls within the 2.5 - 7 mg・kg−1 body mass that has been 426 
shown to be the effective range for inducing improved muscular strength (Astorino and 427 
Roberson 2010a). 428 
Interestingly, the present work is the first to show variation in contractile response 429 
between different concentrations of caffeine. Whilst both the low and moderate 430 
caffeine dose appeared to be effective in increasing peak concentric force of the knee 431 
extensors at 180 deg/s, only the moderate dose induced an improvement in the 432 
sustained contractile performance at this angular velocity. These results indicate that 433 
the effectiveness of different caffeine doses may further depend on the measured 434 
contractile parameter, where some contractility types favour lower caffeine 435 
concentrations.  436 
20 
 
The present work is the first to examine the dose response effect of caffeine on 437 
maximal voluntary force of upper body musculature. The lack of any demonstrated 438 
effect contradicts work conducted by Del Coso, Salinero et al. (2012) who 439 
demonstrated that 3 mg・kg−1 body mass caffeine increased maximal power output 440 
in the bench press, although no effect was demonstrated using a 1 mg・kg−1 body 441 
mass treatment. As such, it is recommended that more work is conducted to evaluate 442 
the dose response effects of caffeine on fixed load strength measures, as these may 443 
offer different results to measures of maximal voluntary force. 444 
Effect of Caffeine on Pain Perception 445 
The present findings demonstrate that during the protocol of repeated contractions for 446 
both the elbow flexors and the knee extensors, there was no effect of either caffeine 447 
dose on pain perception. There is evidence to suggest that mechanistically caffeine 448 
can induce performance enhancing benefits by manipulating pain perception (Doherty 449 
et al. 2005). As there was no change in performance during the repeated contraction 450 
protocol of the elbow flexors, it was unsurprising that perception of pain was not 451 
affected by the caffeine treatment. The improved performance of the knee extensors 452 
during repeated contractions, coincides with the growing body of evidence that 453 
demonstrates a caffeine induced increase in performance without notable modulation 454 
of pain perception (Tallis, Duncan et al. 2013; Duncan et al. 2014; Tallis, Muhammad 455 
et al. 2016). As such, the given improvement in muscle performance demonstrated in 456 
the present study is likely to relate to the action of caffeine as a CNS stimulant (Nehlig 457 
et al. 1992) and (or) its ability to act directly on skeletal muscle (Tallis, Duncan et al. 458 
2015). 459 
Limitations & Future Direction 460 
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A small number of research studies that have examined the effect of caffeine on 461 
exercise performance have used doses greater than the moderate 6 mg・kg−1 body 462 
mass used in the present study (Perkins et al. 1975; Williams et al. 1987; Graham et 463 
al. 1991; Jacobson, Weber et al. 1992; Cohen et al. 1996; Glaister et al. 2012), with 464 
doses up to 13 mg・kg−1 body mass being reported (Pasman et al. 1995). As such, 465 
there is the possibility that higher doses of caffeine may elicit a greater response with 466 
respect to measures of muscular strength. Currently this remains un-researched, as 467 
high doses of caffeine have been associated with adverse effects such as anxiety, 468 
gastrointestinal discomfort, and impairment of fine motor control (Smith 2002; Burke 469 
2008). Such side effects may cause performance to be decreased. Furthermore, it 470 
would have been useful to measure salivary or plasma caffeine concentration following 471 
the administration of each dose. Previous work has indicated a genetic influence with 472 
respect to speed of caffeine metabolism (Yang et al. 2010), and as such, this may 473 
result in an individual dose response effect. 474 
As a positive caffeine response in the concentric action of the knee extensors was 475 
seen at 180 deg/s and not 60 deg/s, future work should consider evaluating the dose 476 
response effect of caffeine using faster contraction speeds. Irrespective of the dose 477 
response relationship, there is a lack of studies that have examined the effect of 478 
caffeine using high speed isokinetic assessments. Furthermore, the present work and 479 
previous literature (Jacobson and Edwards 1991; Astorino, Terzi et al. 2010b; Del 480 
Coso, Salinero et al. 2012) has focused on evaluating the dose response effects of 481 
caffeine in non-specifically trained athletes. Future work should adopt a similar 482 
experimental approach to assess dose response effects of caffeine in resistance 483 
trained participants, where it is proposed that caffeine elicits a greater benefit. 484 
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The present work examines the dose response effect of caffeine at a group level. 485 
Previous literature has indicated that the rate of caffeine digestion and metabolism 486 
may differ between individuals, which has mechanistically been accounted for by 487 
differences in genotype (Astorino and Roberson 2010a). As such, future work should 488 
consider a greater sample size to better understand the dose response effect on an 489 
individual level. 490 
Conclusion 491 
The results of the present study demonstrate that both low and moderate dose caffeine 492 
were effective in increasing peak concentric force of the knee extensors at faster 493 
contraction velocities. There was no effect of either caffeine dose on the concentric or 494 
eccentric action of the elbow flexors, or the eccentric action of the knee extensors. As 495 
such, the findings demonstrate that relatively low doses of caffeine may be effective 496 
to induce some improvements in muscular strength in non-specifically trained 497 
individuals, but this is limited to larger muscle groups of the lower limb. Where caffeine 498 
elicited a performance enhancing effect, there was no clear dose response 499 
relationship with both the low and moderate doses eliciting similar benefits. Only the 500 
moderate dose of caffeine caused an improvement in performance during repeated 501 
concentric contractions of the knee extensors, indicating that the effective caffeine 502 
concentration may be further related to contraction type. The findings demonstrate a 503 
further level of complexity with respect to identifying the optimum conditions for a 504 
caffeine induced increase in muscle strength. 505 
 506 
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FIGURES 664 
Figure 1. The effect of 3 mg・kg−1 and 6 mg・kg−1 body mass caffeine treatment on 665 
peak and average isokinetic concentric (A & C) and eccentric force (B & D) of the 666 
elbow flexor muscles at 60 and 180 deg/s [Data are represented as mean ± SE; n=10]   667 
Figure 2. The effect of 3 mg・kg−1 and 6 mg・kg−1 body mass caffeine treatment on 668 
peak and average isokinetic concentric (A & C) and eccentric force (B & D) of the knee 669 
extensor muscles at 60 and 180 deg/s [Data are represented as mean ± SE; n=10; * 670 
represents statistically significant difference (P=0.033; d=0.68) between Placebo and 671 
6 mg/kg caffeine; # represents statistical tendency (P=0.083; d=0.83) between 672 
Placebo and 3 mg/kg caffeine]   673 
Figure 3. The effect of 3 mg・kg−1 and 6 mg・kg−1 body mass caffeine treatment on 674 
peak isokinetic concentric and eccentric force of the elbow flexors (A & B) and knee 675 
extensors (C & D) over 30 repeated maximal voluntary contractions at 180 deg/s [Data 676 
are represented as mean ± SE; n=10; # represents statistical tendency (P=0.059; 677 
d=0.47) between Placebo and 6 mg/kg caffeine]   678 
Figure 4. The effect of 3 mg・kg−1 and 6 mg・kg−1 body mass caffeine treatment on 679 
perception of pain and HR during measures of isokinetic muscle force [Data are 680 
represented as mean ± SE; n=10; UReps indicates upper body repetitions, LReps 681 
indicates lower body repetitions]  682 
